The ingredient, explained
Sucralose
A published expert safety assessment covers this exact ingredient.
Ingredient guide
What it is and what it does
alpha-D-Galactopyranoside, 1‚6-dichloro-1‚6-dideoxy-beta-D-fructofuranosyl 4-chloro-4-deoxy,
About this ingredient: EU CosIng ingredient registry (via Open Beauty Facts taxonomy) ↗
- Skin conditioning
- A broad cosmetic role for maintaining skin condition. It does not identify a particular clinical benefit.
Function definitions: European Commission ingredient function definitions (SCCNFP/0299/00, pages 16 to 20) ↗
Registry functions describe possible formulation roles, not results for a finished product. A dictionary entry is not an approval or a safety assessment.
A closer look
What the research shows
Safety assessment
Panel judged assessed sugars safe under described cosmetic-use practices and concentrations.
What this does not tell us
Group safety assessment and read-across, not sucralose-specific skin benefit. Budesonide oral vehicle-only use cannot establish sucralose efficacy.
Sources for this summary. PubMed 31170840 ↗
Research review checked Oct 1, 2026
Bounded review of local candidates, exact-name indexed primary journal/PubMed safety and topical searches; not a systematic review.
Ingredient research is not proof that a product containing this ingredient works.
Read the 1 selected study
Safety assessment
Safety Assessment of Monosaccharides, Disaccharides, and Related Ingredients as Used in Cosmetics. ↗
International journal of toxicology · 2019
Follow the formula
Products containing this ingredient
From the wider catalogue. Linked by the ingredient list, without an efficacy ranking.
Names and identifiers
Registry identity
alpha-D-Galactopyranoside, 1‚6-dichloro-1‚6-dideoxy-beta-D-fructofuranosyl 4-chloro-4-deoxy,
- INCI name on ingredient lists
- SUCRALOSE
- CAS registry number
- 56038-13-2
- EC number
- 259-952-2
Sources for this ingredient record
- EU CosIng ingredient registry (via Open Beauty Facts taxonomy) ↗ · ODbL 1.0 (Open Beauty Facts database) · Recorded Aug 8, 2026



